Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

Vlado Perkovic; Jonathan Barratt; Brad Rovin; Naoki Kashihara; Bart Maes; Hong Zhang; Hernán Trimarchi; Dmitrij Kollins; Olympia Papachristofi; Severina Jacinto-Sanders; Tobias Merkel; Nicolas Guerard; Ronny Renfurm; Thomas Hach; Dana V. Rizk

doi:10.1056/nejmoa2410316

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

V Vlado Perkovic (University of New South Wales, Sydney) J Jonathan Barratt B Brad Rovin (Ohio State University Wexner Medical Center, Columbus) N Naoki Kashihara (Kawasaki Medical School, Okayama, Japan) B Bart Maes (AZ Delta, Roeselare, Belgium) H Hong Zhang H Hernán Trimarchi (Hospital Británico, Buenos Aires) D Dmitrij Kollins (Novartis Pharma, Basel, Switzerland) O Olympia Papachristofi (Novartis Pharma, Basel, Switzerland) S Severina Jacinto-Sanders (Novartis Pharma, Basel, Switzerland) T Tobias Merkel (Novartis Pharma, Basel, Switzerland) N Nicolas Guerard (Novartis Pharma, Basel, Switzerland) R Ronny Renfurm (Novartis Pharma, Basel, Switzerland) T Thomas Hach (Novartis Pharma, Basel, Switzerland) D Dana V. Rizk (University of Alabama at Birmingham, Birmingham)

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal New England Journal of Medicine

Volume / Issue Vol. 392, Issue 6

Published February 06, 2025

Pages 531-543

DOI 10.1056/nejmoa2410316

ISSN 0028-4793

Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (15)

V

Vlado Perkovic

University of New South Wales, Sydney

J

Jonathan Barratt

B

Brad Rovin

Ohio State University Wexner Medical Center, Columbus

N

Naoki Kashihara

Kawasaki Medical School, Okayama, Japan

B

Bart Maes

AZ Delta, Roeselare, Belgium

H

Hong Zhang

H

Hernán Trimarchi

Hospital Británico, Buenos Aires

D

Dmitrij Kollins